Hepion Pharmaceuticals (HEPA)
(Delayed Data from NSDQ)
$1.37 USD
+0.08 (6.20%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.40 +0.03 (2.19%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 30% (76 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.00 | 1.35 | 9.99 |
Current Quarter Estimate | NA | 2.87 | 60.00 |
Year Ago Quarter Estimate | -3.48 | -5.36 | 52.54 |
Next Quarter Estimate | NA | 7.43 | 61.00 |
Next Year Estimate | -17.20 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 7.22 | 12.90 | 17.08 |
Next Year | -50.48 | 8.10 | 8.00 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 1.06 | 2.01 |
Price/Cash Flow (MRFY) | NA | 14.08 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -100.99% |
Return on Equity (TTM) | -244.07% | -55.59% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.